Form 8-K - Current report:
SEC Accession No. 0001628280-21-020237
Filing Date
2021-10-19
Accepted
2021-10-19 16:56:07
Documents
12
Period of Report
2021-10-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K xfor-20211014.htm   iXBRL 8-K 38178
  Complete submission text file 0001628280-21-020237.txt   184109

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xfor-20211014.xsd EX-101.SCH 1914
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xfor-20211014_lab.xml EX-101.LAB 25998
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xfor-20211014_pre.xml EX-101.PRE 13731
5 EXTRACTED XBRL INSTANCE DOCUMENT xfor-20211014_htm.xml XML 11887
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38295 | Film No.: 211331711
SIC: 2836 Biological Products, (No Diagnostic Substances)